Related Experiment Video
Updated: Jun 29, 2025

Experimental Endocarditis Model of Methicillin Resistant Staphylococcus aureus MRSA in Rat
Published on: June 4, 2012
Rapid Progression of Aortitis Caused by Methicillin-Sensitive Staphylococcus Aureus in a Patient With Pneumonia: A
Hideya Itagaki1, Tomoya Ooizumi1, Chiho Sanada2
1Department of Emergency and Disaster Medicine, Tohoku Medical and Pharmaceutical University Hospital, Sendai, JPN.
Abstract:
Infected aortic aneurysm is a rare but fatal disease that occurs through various mechanisms. In this report, we describe the case of a patient who was hospitalized for acute pneumonia and developed an infected aortic aneurysm in the descending aorta during the hospitalization. A 73-year-old Japanese man presented to the emergency department with a chief complaint of fever. He had a history of chronic renal failure due to nephrosclerosis and was on regular hemodialysis three times a week. The patient presented with an elevated inflammatory response, anemia, and low platelet counts after various tests. Computed tomography (CT) showed ground-glass opacity in the left lung with a small amount of pleural effusion, leading to a diagnosis of pneumonia. The patient was admitted to the hospital on the same day, and a course of antibiotics (ceftriaxone [CTRX]) was started. On the fourth day of hospitalization, methicillin-susceptible Staphylococcus aureus (MSSA) was detected in the blood sample, which was collected from the patient on the day of admission. The patient was treated for MSSA pneumonia and bacteremia, and the antibiotics were changed to cefazolin (CEZ). Treatment with antimicrobials resulted in a negative blood culture retest on day 5 and improvement of the inflammatory response. On the 12th day, improvements in pneumonia and pleurisy were observed on the CT scan; however, an abnormal bulge was seen on the dorsal side of the descending thoracic aorta with suspected partial vessel wall disruption, suggesting a ruptured infected aortic aneurysm. Despite treatment with antibiotics, the thoracic descending aortic aneurysm continued to dilate with progressing rupture, and the patient died on the 25th day of hospitalization. This is the first report of an infected aneurysm caused by Staphylococcus aureus, despite a negative blood culture. Patients at high risk might develop infected aneurysms, and the possibility of rapid dilation should always be considered.
Insights
This case report details a fatal infected aortic aneurysm in a patient hospitalized for pneumonia. Despite initial antibiotic treatment for Staphylococcus aureus, the aneurysm rapidly progressed, leading to death.
Area of Science:
- Cardiology
- Infectious Diseases
- Vascular Surgery
Background:
- Infected aortic aneurysms are rare but life-threatening vascular complications.
- Prompt diagnosis and treatment are crucial for patient outcomes.
Observation:
- A 73-year-old male with chronic renal failure developed pneumonia and was treated with antibiotics.
- During hospitalization, methicillin-susceptible Staphylococcus aureus (MSSA) bacteremia was identified.
- Despite initial improvement, a rapidly progressing infected descending thoracic aortic aneurysm was diagnosed.
Findings:
- The patient developed an infected aortic aneurysm secondary to MSSA bacteremia.
- The aneurysm showed rapid dilation and rupture despite antimicrobial therapy.
- This is the first reported case of Staphylococcus aureus-induced infected aneurysm with an initial negative blood culture.
Implications:
- High-risk patients, especially those with bacteremia, require vigilant monitoring for infected aneurysms.
- The potential for rapid aneurysm dilation and rupture necessitates prompt recognition and management.
- This case highlights the importance of considering infected aneurysms even with initial negative cultures.
Related Concept Videos
Pneumonia III: Complications and Assessment
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia II: Pathophysiology
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:

